Skip to main content
. 2021 Sep 13;33(6):879–884. doi: 10.1093/icvts/ivab178

Table 2:

Results of the final model of multivariable Cox proportional hazards regression among all patients (n = 261) after propensity matching

Variables HR (95% CI) P-value
Age (years) (n = 261) 1.016 (1.01–1.03) 0.001a
Grade
 Low/intermediate (n = 36) Ref
 High (n = 183) 1.893 (1.09–3.28) 0.023a
Pulmonary metastasectomy
 No (n = 164) Ref
 Yes (n = 55) 0.536 (0.34–0.85) 0.008a
T stageb
 T1 (n = 37) Ref
 T2/3 (n = 182) 1.499 (0.86–2.61) 0.15
Chemotherapyc
 No/unknown (n = 48) Ref
 Yes (n = 171) 0.569 (0.35–0.92) 0.021a
Radiationc
 None (n = 163) Ref
 Yes (n = 56) 0.717 (0.47–1.10) 0.13

Frequencies for each variable are indicated. Cases with missing survival data excluded.

a

Significant.

b

AJCC 7th edition staging for primary sarcoma.

c

Adjuvant and/or neoadjuvant with respect to the primary disease.

CI: confidence interval; HR: hazard ratio; Ref: reference variable.